JPMorgan Chase & Co’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$175K Sell
9,378
-2,305
-20% -$42.9K ﹤0.01% 4520
2025
Q1
$212K Sell
11,683
-446
-4% -$8.09K ﹤0.01% 4411
2024
Q4
$264K Buy
12,129
+1,490
+14% +$32.5K ﹤0.01% 4426
2024
Q3
$291K Buy
10,639
+412
+4% +$11.3K ﹤0.01% 4299
2024
Q2
$265K Sell
10,227
-5,791
-36% -$150K ﹤0.01% 4132
2024
Q1
$481K Buy
16,018
+15,977
+38,968% +$479K ﹤0.01% 3977
2023
Q4
$426 Hold
41
﹤0.01% 5909
2023
Q3
$560 Sell
41
-3
-7% -$41 ﹤0.01% 5750
2023
Q2
$533 Hold
44
﹤0.01% 5632
2023
Q1
$1K Hold
44
﹤0.01% 5641
2022
Q4
$0 Sell
44
-155
-78% ﹤0.01% 5634
2022
Q3
$4K Sell
199
-28,729
-99% -$577K ﹤0.01% 5226
2022
Q2
$555K Buy
28,928
+1,183
+4% +$22.7K ﹤0.01% 3808
2022
Q1
$1.29M Buy
27,745
+4,454
+19% +$207K ﹤0.01% 3461
2021
Q4
$1.65M Sell
23,291
-8,898
-28% -$631K ﹤0.01% 3345
2021
Q3
$3.75M Buy
32,189
+2,814
+10% +$328K ﹤0.01% 2777
2021
Q2
$4.6M Sell
29,375
-124
-0.4% -$19.4K ﹤0.01% 2697
2021
Q1
$5.59M Buy
29,499
+10,500
+55% +$1.99M ﹤0.01% 2562
2020
Q4
$2.38M Buy
18,999
+13,283
+232% +$1.67M ﹤0.01% 2859
2020
Q3
$625K Sell
5,716
-7,019
-55% -$767K ﹤0.01% 3293
2020
Q2
$1.53M Buy
12,735
+9,179
+258% +$1.1M ﹤0.01% 2819
2020
Q1
$357K Buy
3,556
+491
+16% +$49.3K ﹤0.01% 3457
2019
Q4
$743K Buy
3,065
+2,671
+678% +$647K ﹤0.01% 3237
2019
Q3
$65K Buy
394
+60
+18% +$9.9K ﹤0.01% 4142
2019
Q2
$79K Buy
334
+115
+53% +$27.2K ﹤0.01% 4095
2019
Q1
$58K Buy
219
+158
+259% +$41.8K ﹤0.01% 4179
2018
Q4
$6K Buy
61
+3
+5% +$295 ﹤0.01% 4685
2018
Q3
$11K Buy
+58
New +$11K ﹤0.01% 4641